BCYC
Price
$23.45
Change
-$1.04 (-4.25%)
Updated
Apr 19, 6:59 PM EST
13 days until earnings call
CRNX
Price
$42.97
Change
-$0.04 (-0.09%)
Updated
Apr 19, 6:59 PM EST
21 days until earnings call
Ad is loading...

Compare trend and price BCYC vs CRNX

Header iconBCYC vs CRNX Comparison
Open Charts BCYC vs CRNXBanner chart's image
Bicycle Therapeutics
Price$23.45
Change-$1.04 (-4.25%)
Volume$364.56K
CapitalizationN/A
Crinetics Pharmaceuticals
Price$42.97
Change-$0.04 (-0.09%)
Volume$322.82K
CapitalizationN/A
View a ticker or compare two or three
BCYC vs CRNX Comparison Chart

Loading...

BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CRNXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCYC vs. CRNX commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and CRNX is a StrongSell.

COMPARISON
Comparison
Apr 20, 2024
Stock price -- (BCYC: $24.49 vs. CRNX: $43.01)
Brand notoriety: BCYC and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 165% vs. CRNX: 62%
Market capitalization -- BCYC: $930.58M vs. CRNX: $3.35B
BCYC [@Biotechnology] is valued at $930.58M. CRNX’s [@Biotechnology] market capitalization is $3.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $553.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCYC and CRNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 7 TA indicator(s) are bullish while CRNX’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 7 bullish, 3 bearish.
  • CRNX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than CRNX.

Price Growth

BCYC (@Biotechnology) experienced а +8.84% price change this week, while CRNX (@Biotechnology) price change was -10.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.81%. For the same industry, the average monthly price growth was -5.21%, and the average quarterly price growth was +1226.26%.

Reported Earning Dates

BCYC is expected to report earnings on Aug 01, 2024.

CRNX is expected to report earnings on Aug 09, 2024.

Industries' Descriptions

@Biotechnology (-6.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for CRNX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRNX($3.35B) has a higher market cap than BCYC($931M). BCYC YTD gains are higher at: 35.454 vs. CRNX (20.883).
BCYCCRNXBCYC / CRNX
Capitalization931M3.35B28%
EBITDAN/AN/A-
Gain YTD35.45420.883170%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BCYCCRNX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 23 days ago
87%
Bullish Trend 23 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CRNXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWHFX15.02N/A
N/A
Nationwide Bailard Cogntv Val M
FWMIX59.33-0.11
-0.19%
American Funds Washington Mutual F3
BUIIX21.19-0.06
-0.28%
Buffalo International Institutional
IYCEX16.02-0.06
-0.37%
Delaware Ivy Core Equity Fund Class R
APSGX16.67-0.08
-0.48%
MainStay Fiera SMID Growth I

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+12.24%
PHIO - BCYC
41%
Loosely correlated
-1.73%
MLTX - BCYC
39%
Loosely correlated
-2.90%
ORMP - BCYC
35%
Loosely correlated
-5.58%
SAGE - BCYC
34%
Loosely correlated
+3.70%
AXON - BCYC
34%
Loosely correlated
-0.74%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-2.27%
MDGL - CRNX
51%
Loosely correlated
-2.66%
ORMP - CRNX
37%
Loosely correlated
-5.58%
ATNM - CRNX
36%
Loosely correlated
-8.00%
TSVT - CRNX
35%
Loosely correlated
-8.30%
PRME - CRNX
35%
Loosely correlated
-6.90%
More